Apelin/APJ Signaling Is a Critical Regulator of Statin Effects in Vascular Endothelial Cells—Brief Report

Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes

(2011) Nikolaos P. E. Kadoglou et al.   ACTA DIABETOLOGICA

Disruption of the Apelin-APJ System Worsens Hypoxia-Induced Pulmonary Hypertension

(2011) Suparna M. Chandra et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock

(2011) Ganapati H. Mahabeleshwar et al.   IMMUNITY

Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice

(2010) Tim S. Schmidt et al.   CLINICAL SCIENCE

Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2

(2010) Sangeetha Ramesh et al.   JOURNAL OF CLINICAL INVESTIGATION

Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease

(2010) Benjamin Sadowitz et al.   Vascular and Endovascular Surgery

KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium

(2009) R. A. Boon et al.   BLOOD

Kruppel-like factor 2 cooperates with the ETS family protein ERG to activate Flk1 expression during vascular development

(2009) S. M. Meadows et al.   DEVELOPMENT

Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression

(2009) Bo Shen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia

(2008) Ilker Tasci et al.   ATHEROSCLEROSIS

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

(2008) Chao-Yung Wang et al.   TRENDS IN MOLECULAR MEDICINE